A state of marked loss of voluntary mobility in which the limbs remain in whatever posture they are placed is known as catalepsy. Voluntary motion loss, muscle rigidity, fixed posture, and diminished pain sensitivity are all symptoms of catalepsy. It can be a sign of a variety of diseases, including epilepsy, Parkinson's disease, substance abuse, catatonia, schizophrenia, and as a side effect of certain types of schizophrenia treatment. The treatment for catalepsy is determined by the underlying cause of the symptom. Antipsychotic medicines and muscle relaxants are two treatments that may be used to help with catalepsy.
This report contains market size and forecasts of Catalepsy Treatment in Global, including the following market information:
Global Catalepsy Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Catalepsy Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Catalepsy Treatment include Teva Pharmaceutical Industries, Upsher-Smith Laboratories, Piramal Critical Care, Vintage Labs, Saol Therapeutics, Auxilium Pharmaceuticals, Hikma Pharmaceuticals, Cadila Pharmaceuticals and CASI Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Catalepsy Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Catalepsy Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Catalepsy Treatment Market Segment Percentages, by Type, 2021 (%)
Drugs
Psychotherapy
Others
Global Catalepsy Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Catalepsy Treatment Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Catalepsy Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Catalepsy Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Catalepsy Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Catalepsy Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries
Upsher-Smith Laboratories
Piramal Critical Care
Vintage Labs
Saol Therapeutics
Auxilium Pharmaceuticals
Hikma Pharmaceuticals
Cadila Pharmaceuticals
CASI Pharmaceuticals
Covis Pharma
Sumitomo Dainippon Pharma
Biocon
Merck KGaA
Cadila Pharmaceuticals
Eisai
Cipla
Glenmark Pharmaceuticals Limited
Mankind Pharma
Novo Nordisk A/S
Otsuka America Pharmaceutical
WOCKHARDT